PSTV
Plus Therapeutics·NASDAQ
--
--(--)
--
--(--)
PSTV fundamentals
Plus Therapeutics (PSTV) released its earnings on Aug 14, 2025: revenue was 1.39M (YoY +8.68%), missed estimates; EPS was 0.02 (YoY +104.44%), beat estimates.
Revenue / YoY
1.39M
+8.68%
EPS / YoY
0.02
+104.44%
Report date
Aug 14, 2025
Earnings Call
4:00 PM on Aug 14, 2025
Meeting link.EPS
Actual | -4.2 | -6.75 | -5.85 | -10.05 | -4.95 | -3.75 | -4.2 | 0.15 | -2.85 | -3.6 | -2.85 | -2.25 | -2.1 | -0.59 | -1 | -0.55 | -0.75 | -0.45 | -0.37 | -0.38 | -1.19 | 0.02 | ||||||||||
Forecast | -99.75 | -97.65 | -6.75 | -5.7 | -5.45 | -3.45 | -3.6 | -3.525 | -2.95 | -3.25 | -3.0375 | -2.25 | -2.0625 | -1.7267 | -0.8767 | -1.0725 | -1.09 | -0.53 | -0.5625 | -0.4967 | -0.2481 | -0.09 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +95.79% | +93.09% | +13.33% | -76.32% | +9.17% | -8.70% | -16.67% | +104.26% | +3.39% | -10.77% | +6.17% | 0.00% | -1.82% | +65.83% | -14.06% | +48.72% | +31.19% | +15.09% | +34.22% | +23.50% | -379.65% | +122.22% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 118.00K | 185.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100.00K | 200.00K | 506.00K | 1.90M | 1.24M | 1.27M | 1.68M | 1.28M | 1.46M | 1.40M | 1.06M | 1.39M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 300.00K | 1.48M | 733.33K | 1.05M | 1.86M | 1.42M | 1.70M | 1.70M | 1.47M | 1.50M | 1.48M | 1.49M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -66.67% | -86.52% | -31.00% | +80.44% | -33.25% | -10.61% | -1.35% | -24.76% | -0.70% | -6.40% | -28.61% | -6.48% |
Earnings Call
You can ask Aime
What were the key takeaways from Plus Therapeutics’s earnings call?What guidance did Plus Therapeutics's management provide for the next earnings period?What is Plus Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Plus Therapeutics's revenue and profit?What is the market's earnings forecast for Plus Therapeutics next quarter?Did Plus Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Plus Therapeutics's earnings call?What is Plus Therapeutics's gross profit margin?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
